{"id":"W3163517945","doi":"10.2217/nmt-2021-0005","title":"Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Fingolimod; Medicine; Multiple sclerosis; Sphingosine-1-phosphate receptor; Tolerability; Receptor; Clinical trial; Bioinformatics; Internal medicine; Adverse effect; Sphingosine-1-phosphate; Immunology; Sphingosine; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001461062,0.0002787646,0.0003617302,0.0005716226,0.0001310062,0.0002666535,0.0002328744,0.0003945243,0.002111837],"category_scores_gemma":[0.0001101453,0.00004913842,0.0002304738,0.0003136338,0.0001240528,0.0002726904,0.000266214,0.0007236866,0.0007662022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001857716,"about_ca_system_score_gemma":0.0001932906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003523051,"about_ca_topic_score_gemma":0.001129186,"domain_scores_codex":[0.9999422,0.000009806944,0.000007996641,0.000008536947,0.00002292802,0.000008554568],"domain_scores_gemma":[0.9999706,0.000006142695,0.000009369297,7.995018e-7,0.000007303485,0.000005788585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008576726,0.0001563973,0.0003952577,0.005205696,0.0001139636,0.0009363154,0.00007722024,0.000218173,0.03939237,0.002235047,0.01426288,0.9361491],"study_design_scores_gemma":[0.0003438646,0.001793821,0.004484838,0.0009846067,0.0003357747,0.006561623,0.00008529593,0.0003189598,0.02137254,0.001457927,0.9622256,0.00003515828],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01789881,0.9701878,0.001761459,0.001365467,0.000440632,0.00005963079,0.0001959113,0.0001092333,0.007980946],"genre_scores_gemma":[0.08054809,0.9061171,0.002862616,0.001414727,0.0004255194,0.00006134767,0.0005128591,0.00001496248,0.008042625],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002111837,"threshold_uncertainty_score":0.00706476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03393061890345375,"score_gpt":0.2532120185054075,"score_spread":0.2192813996019537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}